Search

Faculty book clubs are one way to engage in discussion and promote action with colleagues around topics that impact our classrooms. One of the many benefits of book clubs is that the format and process can be altered to fit the needs of the intended audience. This paper describes one faculty group's use of three different models of a book club process, which all capitalize on the utility of book clubs to both identify and implement practical strategies for student engagement. The book club resulted from an interdisciplinary college-wide initiative focused on increasing student engagement within a College of Education and Human Services in a large midwestern public university in the United States. The purpose of this paper is to provide a model for book clubs to be used as a professional development opportunity for faculty. Concrete ideas for implementing similar efforts in the university or college setting are shared.

Due to an evidence gap, the emetogenicity of intravenous (IV) pegaspargase was unable to be included in the clinical practice guideline classifying chemotherapy emetogenicity in pediatric patients. This single-center, retrospective chart review describes the proportion of pediatric patients who did not vomit during the acute phase (complete response; CR) after receiving IV pegaspargase and provides an emetogenicity classification using a preexisting framework. Of 44 patients who received IV pegaspargase between 2011 and 2020, 13 received a serotonin receptor antagonist plus dexamethasone or palonosetron alone and all experienced a CR. We, therefore, recommend classifying IV pegaspargase as moderately emetogenic. [ABSTRACT FROM AUTHOR]

Introduction This study aimed to (1) provide up-to-date estimates of how changes in the prevalence of e-cigarette use have been associated with changes in smoking cessation activities and use of licensed treatments among smokers in England and (2) explore any changes in these associations over time. Methods Data were aggregated quarterly on 67 548 past-year smokers between Q1-2007 and Q4-2022. Explanatory variables were the prevalence of (1) current e-cigarette use among smokers and (2) e-cigarette use during a quit attempt. Outcomes were rates of quit attempts and overall quits among past-year smokers, and the quit success rate and use of licensed treatments among those who made a quit attempt. Results The success rate of quit attempts increased by 0.040% (95% CI 0.019; 0.062) for every 1% increase in the prevalence of e-cigarette use during a quit attempt. No clear evidence was found for an association between current e-cigarette use and the quit attempt rate (B adj = 0.008 [95% CI −0.045; 0.061]) or overall quit rate (B adj = 0.063 [−0.031; 0.158]); or between use of e-cigarettes during a quit attempt and the overall quit rate (B adj = 0.030 [−0.054; 0.114]), use of prescription medication (varenicline/bupropion/nicotine replacement therapy [NRT]: B adj = −0.036 [−0.175; 0.102]), or use of over-the-counter NRT (B adj = −0.052 [−0.120; 0.015]). There was no clear evidence this pattern of associations has changed substantially over time. Conclusions Changes in the prevalence of e-cigarette use in England through 2022 have been positively associated with the success rate of quit attempts but not clearly associated with the quit attempt rate, overall quit rate, or use of licensed smoking cessation treatments. Implications If the association between the increase in e-cigarette use and the quit success rate is causal, then the use of e-cigarettes in quit attempts has helped in the region of 30 000 to 50 000 additional smokers in England to successfully quit each year since they became popular in 2013, over and above the number who were quitting before the advent of e-cigarettes. [ABSTRACT FROM AUTHOR]

Introduction: The last 3 years have seen substantial changes in Great Britain (GB) including the COVID‐19 pandemic, cost‐of‐living crisis and policy changes such as minimum unit pricing. We examined changes in purchasing cross‐border, illicit and home‐brewed alcohol among risky drinkers over this period. Methods: Data were used from 22,086 adult (≥18 years) increasing/higher‐risk drinkers (AUDIT‐C ≥5) participating in a monthly cross‐sectional survey between October 2020 and August 2023. We estimated time trends in the proportion reporting obtaining alcohol from: (i) cross‐border (any/within‐GB/international); (ii) illicit; and (iii) home‐brewed sources in the past 6 months. Results: Between October 2020 and August 2023, the proportion reporting cross‐border alcohol purchases increased (from 8.5% to 12.5% overall; prevalence ratio [PR] = 1.47 [95% CI 1.17–1.86]). This was largely driven by an increase in cross‐border purchases abroad (PR = 1.52 [1.13–2.05]), with a smaller, uncertain increase in cross‐border purchases within GB (PR = 1.37 [0.96–1.95]). The prevalence of cross‐border alcohol purchasing was higher in Wales (13.8% [12.3–15.4%]) and Scotland (6.1% [5.4–6.8%]) than England (3.6% [3.3–3.9%]). There was little change in illicit alcohol purchasing in England or Wales (4.1% [3.7–4.4%]; 4.2% [3.2–5.1%]), but in Scotland it fell from 5.7% to 2.4% (PR = 0.42 [0.19–0.81]). Home‐brewed alcohol was rare (GB: 3.1% [2.9–3.4]) and stable. Discussion and Conclusions: The proportion of increasing/higher‐risk drinkers in GB purchasing cross‐border alcohol increased between October 2020 and August 2023, due to an increase in people buying alcohol abroad. Cross‐border alcohol purchases within GB were more commonly reported in Wales and Scotland. The small proportion purchasing illicit alcohol did not change substantially in England or Wales, but fell by half in Scotland. [ABSTRACT FROM AUTHOR]

Background and aims Design Setting Participants Measurements Findings Conclusions In March 2024, the UK government announced plans to introduce a Vaping Products Duty that will tax e‐liquids based on their nicotine strength. This study examined trends in the nicotine strength of e‐liquids used by adult vapers and differences in those currently used across relevant subgroups.Nationally‐representative, cross‐sectional household survey, July 2016 to January 2024.Great Britain.7981 adult vapers.Participants were asked whether the e‐cigarette they mainly use contains nicotine (yes/no) and the e‐liquid strength (no nicotine, >0–≤ 6, 7–11, 12–19 or ≥20 mg/ml). We also collected information on the main device type used (disposable/refillable/pod), age, gender, occupational social grade, history of ≥1 mental health conditions, smoking status and (among past‐year smokers) level of cigarette addiction.The proportion of vapers in England using high‐strength (≥20 mg/ml) e‐liquids increased from an average of 3.8% (95% confidence interval [CI] = 2.9–5.0) up to June 2021 to 32.5% (CI = 27.9–37.4) in January 2024 (the vast majority of whom [93.3% in January 2024] reported using exactly 20 mg/ml; the legal limit). This rise was most pronounced among those using disposable e‐cigarettes, those aged 18‐24 years and all smoking statuses (including never smokers) except long‐term (≥1y) ex‐smokers. Of those surveyed in 2022–2024 in Great Britain, overall, 89.5% (CI = 88.1–90.8) said they usually used e‐cigarettes containing nicotine, 8.7% (CI = 7.5–10.0) used nicotine‐free e‐cigarettes, and 1.8% (CI = 1.2–2.4) were unsure. The proportion using ≥20 mg/ml was higher among those mainly using disposable (47.9%) compared with pod (16.3%) or refillable (11.5%) devices; never smokers (36.0%), current smokers (28.8%) or recent (<1y) ex‐smokers (27.4%), compared with long‐term ex‐smokers (13.9%); and younger (16–24y; 44.2%) compared with older (≥25y; range 9.4–25.1%) age groups. There were no notable differences across other subgroups of interest.Use of high‐strength nicotine e‐liquids in England appears to have increased sharply in recent years. Most adult vapers in Great Britain appear to use e‐cigarettes that contain nicotine but different subgroups use different strengths: nicotine strengths tend to be higher among those who mainly use disposable devices and those aged 16–24y, and lower among long‐term ex‐smokers. [ABSTRACT FROM AUTHOR]

Background: Tobacco smoking affects women's fertility and is associated with substantial risks of adverse pregnancy outcomes. This study explored trends by socioeconomic position in patterns of smoking, use of non-combustible nicotine products, and quitting activity among women of reproductive age in England. Methods: Data come from a nationally representative monthly cross-sectional survey. Between October 2013 and October 2023, 197,266 adults (≥ 18 years) were surveyed, of whom 44,052 were women of reproductive age (18–45 years). Main outcome measures were current smoking, vaping, and use of nicotine replacement therapy (NRT), heated tobacco products (HTPs), and nicotine pouches; mainly/exclusively smoking hand-rolled cigarettes and level of dependence among current smokers; past-year quit attempts among past-year smokers; and success of quit attempts among those who tried to quit. We modelled time trends in these outcomes, overall and by occupational social grade (ABC1 = more advantaged/C2DE = less advantaged). Results: Smoking prevalence among women of reproductive age fell from 28.7% [95%CI = 26.3–31.2%] to 22.4% [19.6–25.5%] in social grades C2DE but there was an uncertain increase from 11.7% [10.2–13.5%] to 14.9% [13.4–16.6%] in ABC1. By contrast, among all adults and among men of the same age, smoking prevalence remained relatively stable in ABC1. Vaping prevalence among women of reproductive age more than tripled, from 5.1% [4.3–6.0%] to 19.7% [18.0–21.5%], with the absolute increase more pronounced among those in social grades C2DE (reaching 26.7%; 23.3–30.3%); these changes were larger than those observed among all adults but similar to those among men of the same age. The proportion of smokers mainly/exclusively smoking hand-rolled cigarettes increased from 40.5% [36.3–44.9%] to 61.4% [56.5–66.1%] among women of reproductive age; smaller increases were observed among all adults and among men of the same age. Patterns on other outcomes were largely similar between groups. Conclusions: Among women of reproductive age, there appears to have been a rise in smoking prevalence in the more advantaged social grades over the past decade. Across social grades, there have been substantial increases in the proportion of women of reproductive age who vape and shifts from use of manufactured to hand-rolled cigarettes among those who smoke. These changes have been more pronounced than those observed in the general adult population over the same period. [ABSTRACT FROM AUTHOR]